Sfoglia per AUTORE
SPERONE P
Collezione AOU San Luigi di Orbassano

  

Items : 20

Gut and local microbiota in patients with cancer: increasing evidence and potential clinical applications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2024 May;197:104328. doi: 10.1016/j.critrevonc.2024.104328. Epub 2024 Mar 13
2024
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Di Maio M; Novello S; Vellani G; Sperone P; Vignani F; Dionisio R; Ferrari G; Paratore C; Valsecchi AA;

Pregnancy in patients with adrenocortical carcinoma: a case-based discussion. in Reviews in endocrine & metabolic disorders / Rev Endocr Metab Disord. 2023 Feb;24(1):85-96. doi: 10.1007/s11154-022-09769-y. Epub 2022 Nov 22.
2023
AOU San Luigi di Orbassano

Terzolo M; Sperone P; Basile V; Puglisi S;

Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Jan;157:103189. doi: 10.1016/j.critrevonc.2020.103189. Epub 2020 Nov 27
2021
AOU San Luigi di Orbassano

Sperone P; Capelletto E; Artusio E; Carnio S; Di Stefano RF; Rapetti S; Audisio M; Bungaro M; Tabbò F; Leone G; Mariniello A; Palesandro E; Bironzo P; Reale ML; Bertaglia V; Passiglia F; Novello S;

Systemic recurrence of endometrial cancer more than 10?years after hysterectomy: a report of two cases and a brief review of the literature. in Journal of the Egyptian National Cancer Institute / J Egypt Natl Canc Inst. 2020 Nov 2;32(1):41. doi: 10.1186/s43046-020-00052-2.
2020
AOU San Luigi di Orbassano

Muratori L; Sperone P; Gorzegno G; La Salvia A; Scagliotti GV;

Prolonged Adrenal Insufficiency After the Discontinuation of Mitotane Therapy. in Endocrine, metabolic & immune disorders drug targets / Endocr Metab Immune Disord Drug Targets. 2020;20(3):485-487. doi: 10.2174/1871530319666190809144620.
2020
AOU San Luigi di Orbassano

Muratori L; Pia A; Reimondo G; Pisano C; La Salvia A; Puglisi S; Scagliotti GV; Sperone P;

Long term control of luteinized thecoma with sclerosing peritonitis with leuprorelin and tamoxifen treatment. in Gynecologic oncology reports / Gynecol Oncol Rep. 2019 Feb 16;28:44-46. doi: 10.1016/j.gore.2019.02.004. eCollection 2019 May.
2019
AOU San Luigi di Orbassano

Muratori L; Gorzegno G; Sperone P; Andreozzi A; Di Maio M; Scagliotti GV;

Target therapies in recurrent or metastatic head and neck cancer: state of the art and novel perspectives. A systematic review. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2019 Jul;139:41-52. doi: 10.1016/j.critrevonc.2019.05.002. Epub 2019 May 3.
2019
AOU San Luigi di Orbassano

Muratori L; La Salvia A; Sperone P; Di Maio M;

Long-term disease control and high clinical benefit in a patient with advanced thyroid cancer treated with lenvatinib. in Future oncology (London, England) / Future Oncol. 2019 Aug;15(24s):3-6. doi: 10.2217/fon-2019-0092. Epub 2019 Aug 6.
2019
AOU San Luigi di Orbassano

Muratori L; Sperone P; Scagliotti GV;

Topoisomerase 2? and thymidylate synthase expression in adrenocortical cancer. in Endocrine-related cancer / Endocr Relat Cancer. 2017 Jul;24(7):319-327. doi: 10.1530/ERC-17-0095. Epub 2017 Apr 21.
2017
AOU San Luigi di Orbassano

Roca E; Berruti A; Sbiera S; Rapa I; Oneda E; Sperone P; Ronchi CL; Ferrari L; Grisanti S; Germano A; Zaggia B; Scagliotti GV; Fassnacht M; Volante M; Terzolo M; Papotti M;

Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. in European urology / Eur Urol. 2014 Apr;65(4):832-8. doi: 10.1016/j.eururo.2013.11.006. Epub 2013 Nov 14.
2014
AOU San Luigi di Orbassano

Berruti A; Fassnacht M; Haak H; Else T; Baudin E; Sperone P; Kroiss M; Kerkhofs T; Williams AR; Ardito A; Leboulleux S; Volante M; Deutschbein T; Feelders R; Ronchi C; Grisanti S; Gelderblom H; Porpiglia F; Papotti M; Hammer GD; Allolio B; Terzolo M; Berruti A; Fassnacht M; Haak H; Else T; Baudin E; Sperone P; Kroiss M; et alii...

Metronomic chemotherapy may be active in heavily pre-treated patients with metastatic adreno-cortical carcinoma. in Journal of endocrinological investigation / J Endocrinol Invest. 2013 Mar;36(3):148-52. doi: 10.3275/8334. Epub 2012 Apr 5.
2013
AOU San Luigi di Orbassano

Ferrero A; Sperone P; Ardito A; Rossi G; Del Buono S; Priola AM; Bracarda S; Taberna E; Terzolo M; Berruti A;

Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma. in European journal of endocrinology / Eur J Endocrinol. 2012 Mar;166(3):451-8. doi: 10.1530/EJE-11-0918. Epub 2011 Dec 21.
2012
AOU San Luigi di Orbassano

Berruti A; Sperone P; Ferrero A; Germano A; Ardito A; Priola AM; De Francia S; Volante M; Daffara F; Generali D; Leboulleux S; Perotti P; Baudin E; Papotti M; Terzolo M;

Ribonucleotide reductase large subunit (RRM1) gene expression may predict efficacy of adjuvant mitotane in adrenocortical cancer. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2012 Jun 15;18(12):3452-61. doi: 10.1158/1078-0432.CCR-11-2692. Epub 2012 Apr 30.
2012
AOU San Luigi di Orbassano

Volante M; Terzolo M; Fassnacht M; Rapa I; Germano A; Sbiera S; Daffara F; Sperone P; Scagliotti G; Allolio B; Papotti M; Berruti A;

Emerging drugs for adrenocortical carcinoma. in Expert opinion on emerging drugs / Expert Opin Emerg Drugs. 2008 Sep;13(3):497-509. doi: 10.1517/14728214.13.3.497.
2008
AOU San Luigi di Orbassano

Berruti A; Ferrero A; Sperone P; Daffara F; Reimondo G; Papotti M; Dogliotti L; Angeli A; Terzolo M;

Long-term disease free survival in a patient with metastatic adreno-cortical carcinoma after complete pathological response to chemotherapy plus mitotane. in Journal of endocrinological investigation / J Endocrinol Invest. 2006 Jun;29(6):560-2. doi: 10.1007/BF03344148.
2006
AOU San Luigi di Orbassano

Sperone P; Berruti A; Gorzegno G; Paccotti P; Terzolo M; Porpiglia F; Angeli A; Dogliotti L;

Recall inflammatory skin reaction after use of pegylated liposomal doxorubicin in site of previous drug extravasation. in The Lancet. Oncology / Lancet Oncol. 2006 Feb;7(2):186-7. doi: 10.1016/S1470-2045(06)70582-4.
2006
AOU San Luigi di Orbassano

Saini A; Berruti A; Sperone P; Bitossi R; Tampellini M; Dogliotti L; Gorzegno G;

Matrix metalloproteinase type 2 expression in malignant adrenocortical tumors: Diagnostic and prognostic significance in a series of 50 adrenocortical carcinomas. in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc / Mod Pathol. 2006 Dec;19(12):1563-9. doi: 10.1038/modpathol.3800683. Epub 2006 Sep 15.
2006
AOU San Luigi di Orbassano

Volante M; Sperone P; Bollito E; Frangipane E; Rosas R; Daffara F; Terzolo M; Berruti A; Papotti M;

Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial. in Endocrine-related cancer / Endocr Relat Cancer. 2005 Sep;12(3):657-66. doi: 10.1677/erc.1.01025.
2005
AOU San Luigi di Orbassano

Berruti A; Terzolo M; Sperone P; Pia A; Della Casa S; Gross DJ; Carnaghi C; Casali P; Porpiglia F; Mantero F; Reimondo G; Angeli A; Dogliotti L;

Three-year findings of an early lung cancer detection feasibility study with low-dose spiral computed tomography in heavy smokers. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2005 Oct;16(10):1662-6. doi: 10.1093/annonc/mdi314. Epub 2005 Jul 8.
2005
AOU San Luigi di Orbassano

Novello S; Fava C; Borasio P; Dogliotti L; Cortese G; Crida B; Selvaggi G; Lausi P; Brizzi MP; Sperone P; Cardinale L; Ferraris F; Perotto F; Priola A; Scagliotti GV;

Pamidronate administration improves the secondary hyperparathyroidism due to "Bone Hunger Syndrome" in a patient with osteoblastic metastases from prostate cancer. in The Prostate / Prostate. 1997 Dec 1;33(4):252-5. doi: 10.1002/(sici)1097-0045(19971201)33:4<252::aid-pros5>3.0.co;2
1997
AOU San Luigi di Orbassano

Berruti A; Sperone P; Fasolis G; Torta M; Fontana D; Dogliotti L; Angeli A;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte